Lumos Pharma (LUMO) Competitor Comparison
We are evaluating the key criteria listed to compare Lumos Pharma (LUMO) against its competitors in the Biotechnology industry.
Market Capitalization
322 / 368Gross Profits
121 / 278Total Revenue
226 / 300EBITDA
121 / 337Free Cashflow
129 / 352Quick Ratio
132 / 357Earnings per Share
290 / 359Dividend yield
0 / 6Total Cash
267 / 358Performance 3 years
176 / 368Performance 5 years
52 / 368Performance 10 years
224 / 368Linearity 3 years
90 / 368Linearity 5 years
85 / 368Linearity 10 years
214 / 368Total Rank
185 / 368Dividend Rank
45 / 368Valuation Rank
215 / 368Piotroski Rank
205 / 368Muliplier Rank
123 / 368Market Capitalization - LUMO ranking 322 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.